Kaleo is a pharmaceutical development and manufacturing company based in Virginia. It lobbies Congress on health and pharmacy matters, including prescription drug pricing and access to epinephrine (a treatment for severe allergic reactions) in schools and community settings. It also engages on medical countermeasures research and related defense and budget issues.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHARLA PENN
The latest disclosures for this client.
WINNING STRATEGIES WASHINGTON
Q1WINNING STRATEGIES WASHINGTON
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
WINNING STRATEGIES WASHINGTON
CHELSEY PENROD HICKMAN
WINNING STRATEGIES WASHINGTON
ROBERT ZUCKER
WINNING STRATEGIES WASHINGTON
WINNING STRATEGIES WASHINGTON
Q3WINNING STRATEGIES WASHINGTON
Q2WINNING STRATEGIES WASHINGTON
Q1